Due to the heterogeneity of glioblastoma and the difficultly of distinguishing all malignant cells in areas with a high content of macrophages without additional markers, regions of the tumors were selected with minimal CD163 infiltration (Figure 3A). The gene discussed is CD163; the disease is glioblastoma.